ACGME Milestones 2.0: why and what’s new for cytopathology?

Nayar, Ritu; Anderson, Scott R.; Dyhdalo, Kathryn S.; Edgar, Laura; Hatlak, Kate; Henderson-Jackson, Evita; McLean, Sydney; Rosenbaum, Michael; Rosenblum, Frida; Naritoku, Wesley Y.

doi:10.1016/j.jasc.2021.04.003

Cited by 6 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These data have yielded valuable information regarding usability, reliability, and face validity that have allowed for significant improvements in Milestones 2.0. 11,17,18 Further updates are anticipated; given the magnitude of change and significant progression toward construct and content validity, the interval between Milestones 2.0 and 3.0 will likely be longer than the 7 years of this initial cycle. That said, the study of Milestones 2.0 actively continues, and numerous opportunities will be available for feedback from stakeholders across the GME community.…”

Section: The Future Of the Milestonesmentioning

confidence: 99%

Introducing the Neurology Milestones 2.0

et al. 2022

Self Cite

View full text Add to dashboard Cite

The turn of the 21st century heralded a new era in medical education. The Institute of Medicine reports To Err is Human and Crossing the Quality Chasm called for reform of the health care system to improve the quality and safety of patient care.1,2 Concurrently, interest in competency-based medical education increased, and the alignment of an outcomes-based approach to education with the Institute for Healthcare Improvement's “Triple Aim” of health care set the stage for the ongoing transformation in medical education.3,4 A major component of this transformation, specific to graduate medical education (GME), has been the Next Accreditation System (NAS) of The Accreditation Council for Graduate Medical Education (ACGME).

show abstract

Section: The Future Of the Milestonesmentioning

confidence: 99%

Introducing the Neurology Milestones 2.0

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…Training in Cytopathology includes more than obtaining medical knowledge and skill. At the end of the training, one must be deemed competent in all the six general competencies which are medical knowledge, patient care, interpersonal and communication skills, practice‐based learning and improvement, professionalism, and systems‐based practice 4 preparing them for independent practice and professional development. The stay‐at‐home order markedly compromised interpersonal communications within the department, and outside with medical and non‐medical staff.…”

Section: Introductionmentioning

confidence: 99%

COVID and cytopathology training: Impact and innovations

Das

2024

Diagnostic Cytopathology

View full text Add to dashboard Cite

Graduate medical education and training in Cytopathology faced numerous unexpected challenges during the COVID‐19 pandemic of 2020. It was caused by the SARS‐Co‐V2 coronavirus and transmitted by breathing droplets or aerosol particles containing the virus and less commonly by contact with infected surfaces and fomites. To mitigate the rapid spread of disease non‐essential services were closed, surgical procedures were prioritized, and “social distancing” was implemented. These measures led to a marked decline in the volume of specimens, number of fine needle aspiration (FNA) and rapid on‐site evaluation procedures performed. The trainees in Pathology were required to stay at home either entirely or partly during the early period of the pandemic. This led to re‐designing of the cytopathology training program nationwide. Many innovative methods and protocols were put in place to overcome the challenges faced and adjustments made in creating the virtual training program in Cytopathology. On May 5th, 2023, the WHO declared that COVID‐19 was no longer a global emergency. Regulations were lifted and healthcare services returned to pre‐pandemic era. Graduate medical education and training returned to normal however many changes were incorporated into the training program moving forward. Herein the impacts and innovations that COVID‐19 had on Cytopathology training are described.

show abstract

From observation to judgment: Making sense of milestones 2.0 for cytopathology

LaRochelle

2021

Cancer Cytopathology

View full text Add to dashboard Cite

ACGME Milestones 2.0: why and what’s new for cytopathology?

Cited by 6 publications

References 9 publications

Introducing the Neurology Milestones 2.0

Introducing the Neurology Milestones 2.0

COVID and cytopathology training: Impact and innovations

From observation to judgment: Making sense of milestones 2.0 for cytopathology

Contact Info

Product

Resources

About